Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
LISOCABTAGENE MARALEUCEL; UP TO 110 MILLION AUTOLOGOUS ANTI-CD19 CAR-POSITIVE VIABLE T CELLS; INCLUDING LEUKAPHERESIS AND DOSE PREPARATION PROCEDURES; PER THERAPEUTIC DOSE
Little Rock, AR
See all hospitals reporting HCPCS Q2054 →Price type
University of Arkansas for Medical Sciences’s median price of $579.1k is 2% below the median hospital's median price ($591.2k), higher than 43% of the 1,128 hospitals reporting HCPCS Q2054. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Last updated: Jun 17, 2026
See Lisocabtagene maraleucel CAR-T cell therapy dose pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.